Skip to main content

NCI Renews Partnership with UNC to Seek New Cancer Drugs

October 6, 2016

The University of North Carolina at Chapel Hill will pursue treatments for specific cancer targets as a specialized member of the National Cancer Institute’s renewed Experimental Therapeutics, or NExT, program through a contract with Leidos Biomed and its Frederick National … Read more

Video: Drug Discovery Center Draws on UNC Bench Science

November 3, 2014

UNC News Services and the University Gazette interviewed School faculty member Stephen Frye, PhD, about the work being done at the Center for Integrative Chemical Biology and Drug Discovery in Marsico Hall. Read the Gazette article here.

Eshelman Gives $3 Million to School’s Drug-Discovery Center

September 3, 2014

The UNC Eshelman School of Pharmacy has received a $3 million gift from philanthropist and pharmaceutical-industry executive Fred Eshelman. Eshelman’s gift will support the work of the School’s Center for Integrative Chemical Biology and Drug Discovery.  The center is dedicated … Read more

School Researchers Discover First-in-Class Chemical Probe

March 7, 2013

A team of scientists led by researchers at the UNC Eshelman School of Pharmacy have discovered a first-in-class chemical probe that will give researchers a powerful tool to investigate the function of malignant brain tumor domains in biology and disease. … Read more

Frye Awarded $1 Million Eshelman Professorship

July 26, 2012

The UNC Eshelman School of Pharmacy has named Stephen Frye, PhD, as the recipient of a $1 million Eshelman Distinguished Professorship. Frye is the director of the School’s Center for Integrative Chemical Biology and Drug Discovery, a research group bringing … Read more

Frye Promoted to Full Professor with Tenure

November 23, 2011

The University of North Carolina at Chapel Hill Board of Trustees has approved the promotion of Stephen Frye, PhD, to the rank of full professor with tenure in the UNC Eshelman School of Pharmacy. Frye is the director of the … Read more

Frye Awarded Two NCI Drug-Discovery Contracts

October 6, 2010

As part of a national effort to accelerate the identification and testing of new anticancer drugs, SAIC-Frederick, Inc., a prime contractor to the National Cancer Institute has awarded two contracts totaling $2.4 million to two teams of UNC scientists to … Read more